Prime Highlights
- Haleon and Microsoft have signed a five-year agreement to scale AI use across consumer insights, marketing, R&D and supply chain functions.
- The partnership aims to strengthen data governance across 170 countries while improving speed to market for health innovations.
Key Facts
- Haleon is a global consumer health company using Microsoft Azure and Copilot to support its digital transformation.
- The collaboration targets predictive supply chain analytics and personalised marketing across six product categories.
Background
Haleon has entered a five-year agreement with Microsoft to expand its use of cloud and artificial intelligence technology across its global business. Building on productivity advantages already achieved through prior collaboration, the consumer health company will continue to use Microsoft Azure as its primary cloud platform while incorporating Microsoft Copilot into its day-to-day operations.
Claire Dickson, Chief Digital and Technology Officer at Haleon, said the partnership marked a significant step in how the company uses digital tools, data and AI to support its global strategy. She noted that AI capabilities were already embedded across consumer insights, marketing, research and development, and supply chain functions, delivering measurable efficiencies. Combining Microsoft’s cloud and AI strengths with Haleon’s consumer health expertise would help simplify workflows, unlock greater value from data and support faster decision-making, she added.
Darren Hardman, CEO of Microsoft UK and Ireland, said Haleon was progressing quickly on its AI journey and turning ambition into real impact across the organisation. He added that Microsoft was proud to support Haleon in scaling AI securely, helping the company advance its mission of delivering better everyday health outcomes worldwide.
The agreement strengthens data governance across Haleon’s 170 operating countries and supports predictive analytics to help prevent supply chain disruptions affecting essential medicines and health products. Marketing teams will use the infrastructure to build personalised, compliant campaigns across six product categories, while Copilot adoption is expected to reduce administrative work and speed up clinical content production. The collaboration aims to benefit more than one billion consumers globally.
